Hologic Stock Performance
| HOLX Stock | USD 60.43 1.34 2.17% |
The company retains a Market Volatility (i.e., Beta) of -0.11, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Hologic are expected to decrease at a much lower rate. During the bear market, Hologic is likely to outperform the market. At this point, Hologic has a negative expected return of -0.23%. Please make sure to check out Hologic's jensen alpha, skewness, as well as the relationship between the Skewness and day typical price , to decide if Hologic performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Hologic has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in May 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Actual Historical Performance (%)
One Day Return (0.63) | Five Day Return (1.25) | Year To Date Return (14.44) | Ten Year Return 86.31 | All Time Return 2.5 K |
Last Split Factor 2:1 | Last Split Date 2008-04-03 |
1 | Quent Capital LLC Sells 315 Shares of Hologic, Inc. | 02/14/2025 |
2 | Hologic to Webcast Presentation at the Raymond James 46th Annual Institutional Investors Conference | 02/25/2025 |
3 | Acquisition by Stamoulis Christiana of 1864 shares of Hologic subject to Rule 16b-3 | 02/28/2025 |
4 | Disposition of 5093 shares by Benjamin Cohn of Hologic at 81.989 subject to Rule 16b-3 | 03/07/2025 |
5 | Hologic Inc Stock Price Down 4.72 percent on Mar 11 | 03/11/2025 |
6 | Investors Heavily Search Hologic, Inc. Here is What You Need to Know | 03/19/2025 |
7 | Noul Showcases AI-Powered Cervical Cancer Cell Screening Technology at NVIDIA GTC 2025 | 03/20/2025 |
8 | FY2025 EPS Estimates for Hologic Reduced by Zacks Research | 03/21/2025 |
9 | Hologic Advances But Underperforms Market Key Facts | 03/24/2025 |
10 | Illumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors | 03/25/2025 |
11 | After her breast cancer diagnosis, Gaby Dabrowski found unexpected joy and success on the tennis court | 03/26/2025 |
12 | Liposuction Surgery Devices Growth Trends Report 2025 Global Market to Reach 5.24 Billion by 2033, Driven by Emerging Regions, Growing Cultural Acceptance, and ... | 03/27/2025 |
| Begin Period Cash Flow | 2.8 B |
Hologic |
Hologic Relative Risk vs. Return Landscape
If you would invest 7,174 in Hologic on January 2, 2025 and sell it today you would lose (997.00) from holding Hologic or give up 13.9% of portfolio value over 90 days. Hologic is currently does not generate positive expected returns and assumes 1.8585% risk (volatility on return distribution) over the 90 days horizon. In different words, 16% of stocks are less volatile than Hologic, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Hologic Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Hologic's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Hologic, and traders can use it to determine the average amount a Hologic's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1223
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | HOLX |
Estimated Market Risk
| 1.86 actual daily | 16 84% of assets are more volatile |
Expected Return
| -0.23 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Hologic is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Hologic by adding Hologic to a well-diversified portfolio.
Hologic Fundamentals Growth
Hologic Stock prices reflect investors' perceptions of the future prospects and financial health of Hologic, and Hologic fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Hologic Stock performance.
| Return On Equity | 0.16 | ||||
| Return On Asset | 0.071 | ||||
| Profit Margin | 0.18 % | ||||
| Operating Margin | 0.23 % | ||||
| Current Valuation | 14.43 B | ||||
| Shares Outstanding | 225.72 M | ||||
| Price To Earning | 10.21 X | ||||
| Price To Book | 2.90 X | ||||
| Price To Sales | 3.43 X | ||||
| Revenue | 4.03 B | ||||
| Gross Profit | 2.46 B | ||||
| EBITDA | 1.3 B | ||||
| Net Income | 789.5 M | ||||
| Cash And Equivalents | 2.39 B | ||||
| Cash Per Share | 9.59 X | ||||
| Total Debt | 2.66 B | ||||
| Debt To Equity | 0.57 % | ||||
| Current Ratio | 3.90 X | ||||
| Book Value Per Share | 21.16 X | ||||
| Cash Flow From Operations | 1.29 B | ||||
| Earnings Per Share | 3.16 X | ||||
| Market Capitalization | 13.94 B | ||||
| Total Asset | 9.16 B | ||||
| Retained Earnings | 2.85 B | ||||
| Working Capital | 2.79 B | ||||
| Current Asset | 137.94 M | ||||
| Current Liabilities | 39.47 M | ||||
About Hologic Performance
Evaluating Hologic's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Hologic has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Hologic has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 115.08 | 118.62 | |
| Return On Tangible Assets | 0.09 | 0.10 | |
| Return On Capital Employed | 0.08 | 0.08 | |
| Return On Assets | 0.05 | 0.04 | |
| Return On Equity | 0.09 | 0.10 |
Things to note about Hologic performance evaluation
Checking the ongoing alerts about Hologic for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Hologic help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Hologic generated a negative expected return over the last 90 days | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from businesswire.com: Liposuction Surgery Devices Growth Trends Report 2025 Global Market to Reach 5.24 Billion by 2033, Driven by Emerging Regions, Growing Cultural Acceptance, and Rising Fitness Trends - ResearchAndMarkets.com |
- Analyzing Hologic's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Hologic's stock is overvalued or undervalued compared to its peers.
- Examining Hologic's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Hologic's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Hologic's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Hologic's stock. These opinions can provide insight into Hologic's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Hologic Stock Analysis
When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.